期刊文献+

禽腺病毒载体研究进展 被引量:4

Progress on Fowl Adenovirus Vector
下载PDF
导出
摘要 人腺病毒载体被广泛地用作转基因工具。然而,人体内预先存在的针对人腺病毒的抗体影响了转基因的效率,阻碍了这些载体在临床上的应用。避免宿主免疫反应的途径之一是开发能将基因转导至人细胞的动物腺病毒载体,而禽腺病毒载体是目前动物腺病毒载体研究中较多的一种。禽腺病毒载体还可插入并表达病原的保护性抗原基因,用于疫苗研制。对禽腺病毒的分子生物学和载体疫苗的深入研究,将对禽类疫病预防起到重要作用。论文详细叙述了禽腺病毒的基因组结构特点以及禽腺病毒载体的研究现状,为研究者提供参考。 Human adenovirus vectors are extensively used as gene transfer vehicles.However,a serious obstacle for the use of these vectors in clinical applications is due to preexistent immunity to human adenovirus affecting the efficacy of gene transfer.One of the approachs to circumvent host immune response could be the development of vectors based on animal adenovirus that are able to transduce genes into human cells,and research work on fowl adenovirus vectors was extensively made currently.Fowl adenovirus vectors could also be used for vaccine development as they were capable of expressing an inserted gene of pathogenic protective antigen.Indepth research on molecular biology and vaccine development of fowl adenovirus would play an important role in prevention of avain diseases.The paper reviewed research progress on the construction of fowl adenovirus vectors in detail as well as genome structure and characterization of fowl adenovirus,which provides references for researchers.
出处 《动物医学进展》 CSCD 北大核心 2012年第11期99-103,共5页 Progress In Veterinary Medicine
基金 上海市自然科学基金项目(№09140901400)
关键词 人腺病毒 禽腺病毒 鸡胚致死孤儿病毒 载体 Human adenovirus Fowl adenovirus Chicken embryo lethal orphan virus vector
  • 相关文献

参考文献24

  • 1Michou A I, Lehrmann H, Saltik M, et ai. Mutational analysis of the avain adenovirus CELO, which provides a basis for gene delivery vector [J]. J Virol, 1999, 73 (2) : 1399-1410.
  • 2Francois A, Eterradossi N, Delmas B, et al. Construction of avain adenovirus CELO recombinants in cosmids [J]. J Virol, 2001, 75(11) :5288-5301.
  • 3Washietl S, Eisenhaber F. Reannotation of the CELO genome characterizes a set of previously unassigned open reading frames and points to novel modes of host interaction in avain adenoviruses[J]. BMC Bioinformations, 2003, 4:55-72.
  • 4Logunov D Y, Ilyinskaya G V, Cherenova L V, et al. Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avain ade- novirus CELO-p53 [J]. Gene Therapy, 2004, 11:79-84.
  • 5Francois A, Chevalier C, Delmas B, et al. Avain adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens [J]. Vaccine, 2004, 22:2351-2360.
  • 6Cherenova L V, Logunov D Y, Shashkova E V, et al. Recombinant avain adenovirus CELO expressing the hunman interleu-kin-2: characterization in vitro, in ovo and in vivo [J]. Virus Res, 2004, 100:257-261.
  • 7Le Goff F, Mederle-Mangeot I, Jestin A, et al. Deletion of open reading frame 9, 10 and 11 from the avain adenovirus CE- LO genome: effect on biodistribution and humoral responses [J]. J Gen Virol, 2005, 86:2019-2027.
  • 8Shashkova E V, Cherenova L V, Kazansky D B, et al. Avain adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors [J]. Cancer Gene Therapy, 2005, 12 : 617-626.
  • 9Stevenson M, Boos E, Herbert C, et al. Chick embryo lethal orphan virus can be polymer-coated and retargeted to infect mammalian cells [J]. Gene Therapy, 2006, 13 :356- 368.
  • 10Rauw F, Lambrecht B, Francois A, et al. Kinetic and biologic properties of recombinant chIFN-7 expressed via CELO-virus vector [J]. J Interferon Cytokine Res, 2007, 27 : 111- 118.

同被引文献26

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部